Geneva - The Global Fund to Fight
AIDS, Tuberculosis and Malaria today announced that 2.3 million people
living with HIV have been reached with lifesaving antiretroviral (ARV)
treatment through AIDS programs it supports, a 31 per cent increase over
results reported a year ago.

Global Fund-supported tuberculosis programs
have so far put more than 5.4 million people on effective TB drugs treatment.
Tuberculosis is the leading cause of death among HIV-infected people; the
World Health Organization estimates that TB accounts for up to a …

This fact sheet outlines the principles and approach in determining the number of people on antiretroviral drugs (ARVs) for HIV/AIDS treatment, with a breakdown of the results by country, and answers to commonly-asked questions.

Question 1: How many people are receiving ARVs from programs supported by Global Fund grants?

As of June 1st 2009, programs supported by the Global Fund have reported 2.3 million people currently on ARVs for treatment of HIV/AIDS.

Question 2: What is the regional breakdown of people currently receiving ARVs?